Search results

Jump to navigation Jump to search
  • == Allergen Immunotherapy == ...[[allergies]]. It is a form of long-term treatment that decreases symptoms for many people with [[allergic rhinitis]], [[allergic asthma]], [[conjunctivit
    2 KB (258 words) - 06:40, 11 February 2024
  • ==Cancer Immunotherapy== '''Cancer immunotherapy''' (pronunciation: /ˈkænsər ˌɪm.juː.nəʊˈθɛrəpi/) is a type of [
    2 KB (236 words) - 22:34, 7 February 2024
  • ...signed for the treatment of various types of [[cancer]]. It is a type of [[immunotherapy]] that targets and binds to the [[MUC1]] protein, which is overexpressed in ...ame "Gatipotuzumab" follows the [[World Health Organization]]'s guidelines for the nomenclature of monoclonal antibodies. The suffix "-mab" indicates that
    1 KB (193 words) - 04:19, 7 February 2024
  • == Active Immunotherapy == ...(pronounced as ak-tiv im-yuh-noh-ther-uh-pee) is a form of [[Immunotherapy|immunotherapy]] that stimulates the body's immune system to fight diseases such as [[Canc
    2 KB (227 words) - 04:11, 11 February 2024
  • ...signed for the treatment of certain types of [[cancer]]. It is a type of [[immunotherapy]] that uses the body's immune system to help fight cancer. ...es (INN), where "mab" stands for monoclonal antibody, "tu" for tumor, "re" for rat (indicating the murine origin of the antibody), and "min" is a prefix u
    2 KB (219 words) - 02:50, 7 February 2024
  • ...nal antibody]] designed for the treatment of [[cancer]]. It is a type of [[immunotherapy]] that targets the [[CXCR4]] protein, which is overexpressed in many types ...stem is used for immunomodulating antibodies, and the "pl-" infix is used for the [[lymphocyte]]s.
    1 KB (211 words) - 00:18, 7 February 2024
  • ...at-li-mab) is a novel [[immunotherapy]] drug currently under investigation for its potential use in the treatment of [[melanoma]], a type of [[skin cancer ...es (INN) system for pharmaceutical substances. The "-limab" suffix is used for human monoclonal antibodies, while the prefix "Relat-" is unique to the dru
    2 KB (260 words) - 04:53, 6 February 2024
  • ...designed for the treatment of various [[cancer]] types. It is a type of [[immunotherapy]] that works by stimulating the body's immune system to attack cancer cells ...globulin (a type of protein), "tu" stands for tumor, and "mab" is a suffix for monoclonal antibodies.
    2 KB (228 words) - 14:46, 6 February 2024
  • ...research, development, and commercialization of novel biological products for the treatment and prevention of [[cancer]]. ...cine. The name reflects the company's primary focus on developing vaccines for cancer treatment.
    1 KB (193 words) - 16:39, 5 February 2024
  • ...nal antibody]] designed for the treatment of [[cancer]]. It is a type of [[immunotherapy]] that targets specific cells to stimulate the body's immune system to atta ..." follows the [[International Nonproprietary Names|INN]] naming convention for monoclonal antibodies, with the suffix "-mab" indicating it is a monoclonal
    1 KB (144 words) - 23:22, 5 February 2024
  • ...signed for the treatment of certain types of [[cancer]]. It is a type of [[immunotherapy]] that uses the body's immune system to help fight cancer. ...he Greek word "dothien" meaning "to give"), and "tuximab" (a common suffix for monoclonal antibodies).
    1 KB (211 words) - 17:41, 6 February 2024
  • ...designed for the treatment of various [[cancer]] types. It is a type of [[immunotherapy]] that targets specific cells to enhance the body's immune response against ...uzu" is a stem used for humanized antibodies, and "mab" is a common suffix for monoclonal antibodies.
    1 KB (194 words) - 02:35, 7 February 2024
  • ...f [[renal cell carcinoma]], a type of [[kidney cancer]]. It is a type of [[immunotherapy]] that targets carbonic anhydrase IX (CAIX), a protein that is overexpresse ...name "Girentuximab" follows the [[World Health Organization]]'s guidelines for the nomenclature of monoclonal antibodies. The prefix "Giren-" is randomly
    1 KB (202 words) - 23:45, 6 February 2024
  • ...from the Latin ''detumo'', meaning "I swell", and ''mab'', an abbreviation for monoclonal antibody. This reflects the drug's function in targeting swollen ...to specific proteins on the surface of cancer cells, thereby marking them for destruction by the body's immune system.
    1 KB (211 words) - 16:32, 5 February 2024
  • ...nal antibody]] designed for the treatment of [[cancer]]. It is a type of [[immunotherapy]] that targets and binds to the [[Programmed cell death protein 1|PD-1]] re ...for [[peptide]], "idi" for [[idiotype]], "lizu" for [[lizard]], and "mab" for [[monoclonal antibody]]. The "lizard" part of the name is a tribute to the
    2 KB (236 words) - 17:39, 6 February 2024
  • ...designed for the treatment of various [[cancer]] types. It is a type of [[immunotherapy]] that targets the [[CD4]] molecule on the surface of certain [[white blood ..." follows the [[International Nonproprietary Names|INN]] naming convention for monoclonal antibodies, with the suffix "-mab" indicating it is a monoclonal
    1 KB (178 words) - 00:10, 7 February 2024
  • '''Neuvenge''' (pronounced: noo-venj) is a type of [[immunotherapy]] used in the treatment of certain types of [[cancer]], specifically [[pros ...a brand name and does not have a known etymology. It is a proprietary name for the drug [[sipuleucel-T]], which is produced by the pharmaceutical company
    2 KB (238 words) - 05:52, 5 February 2024
  • ...ab''' (pronounced: ten-eh-lix-i-mab) is a [[monoclonal antibody]] designed for the treatment of various [[autoimmune diseases]]. ...y, while the prefix "Teneli-" does not have a specific meaning and is used for unique identification.
    2 KB (217 words) - 23:56, 6 February 2024
  • ...l antibody]] used in cancer treatment. It is currently under investigation for its potential use in the treatment of various types of [[cancer]], includin ..."li" signifies immunoglobulin, "tuz" indicates humanized, and "mab" stands for monoclonal antibody.
    2 KB (239 words) - 04:20, 7 February 2024
  • ...figure in the field of [[oncology]], specifically known for her work in [[immunotherapy]] and [[pancreatic cancer]] research. ...Her research primarily focuses on the development of [[vaccine]] therapies for pancreatic cancer.
    2 KB (203 words) - 20:40, 9 February 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)